Skip to main content
Inify Laboratories AB logo

Inify Laboratories AB — Investor Relations & Filings

Ticker · INIFY ISIN · SE0017486103 LEI · 549300306YYJ3BX3VB98 ST Human health and social work activities
Open in API
Filings indexed 339 across all filing types
Latest filing 2025-12-19 Director's Dealing
Country SE Sweden
Listing ST INIFY

About Inify Laboratories AB

https://www.inify.com/

Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. The company utilizes a fully digital, standardized, and AI-supported workflow for histopathology analysis. This integrated service model is designed to optimize the entire diagnostic process, from sample receipt to final report, ensuring high quality and significantly reduced turnaround times for clinical partners. Initially focused on prostate cancer, the company has expanded its diagnostic capabilities to include other areas such as gastroenterology. By streamlining the clinical pathway, Inify Laboratories enables healthcare providers to receive faster results, which facilitates earlier patient follow-up and treatment planning.

Recent filings

Filing Released Lang Actions
Inify Laboratories - mandatory notification of trade - Attachment: Inify_Laboratories_PDMR_attachment.pdf
Director's Dealing Classification · 100% confidence The document follows the standard regulatory format for reporting transactions by persons discharging managerial responsibilities (PDMRs) or persons closely associated with them, as required by market abuse regulations (MAR). It explicitly lists the names of the entities, their relationship to a board member (Magne Jordanger), the nature of the transaction (subscription to new shares in a private placement), and the specific price and volume details. This is a classic 'Director's Dealing' or 'Insider Trading' notification.
2025-12-19 English
Inify Laboratories - mandatory notification of trade
Director's Dealing Classification · 100% confidence The document is a mandatory notification of trade regarding shares allocated to companies associated with a board member (insider) following a private placement. This falls under the category of Director's Dealing (DIRS), as it reports personal/associated share transactions by company insiders as required by the EU Market Abuse Regulation.
2025-12-19 English
Inify Laboratories - mandatory notification of trade
Director's Dealing Classification · 100% confidence The document follows the standard regulatory format for reporting transactions by persons discharging managerial responsibilities (PDMRs) or persons closely associated with them, as required by market abuse regulations (MAR). It explicitly lists the names of the entities, their relationship to a board member (Magne Jordanger), the nature of the transaction (subscription to new shares in a private placement), and the specific price and volume details. This is a classic 'Director's Dealing' or 'Insider Trading' notification.
2025-12-19 English
Inify Laboratories announces final results of fully guaranteed private placement
Capital/Financing Update Classification · 100% confidence The document is a formal announcement regarding the final results of a private placement and a repair issue of shares for Inify Laboratories AB. It details the number of shares issued, the gross proceeds, the settlement timeline, and the regulatory context (Norwegian Securities Trading Act). It is a corporate announcement regarding capital structure changes and financing activities, which fits the 'Capital/Financing Update' category.
2025-12-19 English
Inify Laboratories announces final results of fully guaranteed private placement - Attachment: Inify_laboratories_Final_results_private_placement.pdf
Capital/Financing Update Classification · 100% confidence The document is a formal announcement regarding the final results of a private placement and a repair issue of shares for Inify Laboratories AB. It details the number of shares issued, the gross proceeds, the settlement timeline, and the regulatory context (Norwegian Securities Trading Act). It is a corporate announcement regarding capital structure changes and financing activities, which fits the 'Capital/Financing Update' category.
2025-12-19 English
Inify Laboratories announces final results of fully guaranteed private placement
Capital/Financing Update Classification · 100% confidence The document is a press release announcing the final results of a private placement and a repair issue of shares. It details the number of shares issued, the gross proceeds, the allocation to guarantors, and the timeline for settlement and future subscription periods. This falls under the category of capital and financing updates, as it describes the company's fundraising activities and changes to its capital structure.
2025-12-19 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.